It was revealed in the journal Nature that a new method allows researchers to peer into the brains of patients and see the tell-tale protein clumps thought to underlie Alzheimer's disease. The method may help doctors with diagnosis, and should boost disease monitoring and drug development.

With triangulation of method this can bring confirmation of the condition to a much lower threshold, coupled with early detection and monitoring over the web.